ImmuDyne, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 9/07/2016
Contact Info
  • 50 Spring Meadow Rd
  • Mount Kisco, NY 10549

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000948320
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark McLaughlin President, CEO
John Strawn Legal Counsel
Sven Rohmann CMO
Joseph DiTrolio CMO
Company Directors
Anthony Bruzzese, M.D. Chairman
Joseph DiTrolio
Sven Rohmann
John Strawn
Company Notes
  • Formerly=Anina Resources, Inc to 11-87
Service Providers
Accounting/Auditing Firm
29 Broadway
New York, NY, 10006
United States

Legal Counsel
Kane Kessler, P.C.
1350 Avenue of the Americas
New York, NY, 10019
United States

Investor Relations Firm
Not Available
IMMD Security Details
Share Structure
Market Value1 $8,752,577 a/o Oct 21, 2016
Authorized Shares 50,000,000 a/o May 06, 2015
Outstanding Shares 34,310,375 a/o Aug 15, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 11,490,119 a/o Aug 15, 2016
Par Value 0.01
Shareholders of Record 308 a/o Aug 15, 2016
Short Selling Data
Short Interest 600 (-73.39%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security